Atara Biotherapeutics, Inc. Common Stock (NASDAQ: ATRA) last traded at $9.38, down 1.05% on the session. The quote above updates while this page is open; the figures below are drawn from Atara Biotherapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Atara Biotherapeutics, Inc. Common Stock trades on NASDAQ under the ticker ATRA. Its market capitalisation is $94.15 million.
Valuation measures for Atara Biotherapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $94.15M |
|---|---|
| Enterprise value | $148.95M |
| Price / sales | 15.20 |
| Beta | 1.17 |
Trailing-twelve-month figures tagged in Atara Biotherapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) |
|---|
| $6.19M |
| Net income (TTM) | -$16.69M |
|---|
| EPS (TTM) | -$1.73 |
|---|
| Operating margin | -229.67% |
|---|
| Cash | $3.22M |
|---|
Range and volume for ATRA over the past 52 weeks.
| 52-week high | $19.15 |
|---|---|
| 52-week low | $3.92 |
| Volume | 26.8K |
| Average volume | 52.7K |
| Previous close | $9.48 |
Invest a chosen dollar amount in Atara Biotherapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell ATRA.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.